Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA
Open Access
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 139, 65-71
Abstract
No abstract availableKeywords
Funding Information
- GSK (HO-15-15257)
This publication has 33 references indexed in Scilit:
- Combination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseRespiratory Research, 2013
- Pharmacology and Therapeutics of BronchodilatorsPharmacological Reviews, 2012
- Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomesPrimary Care Respiratory Journal, 2012
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- Disease severity and symptoms among patients receiving monotherapy for COPDPrimary Care Respiratory Journal, 2010
- The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPDPulmonary Pharmacology & Therapeutics, 2010
- Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2009
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysisThorax, 2006
- A chronic disease score from automated pharmacy dataJournal of Clinical Epidemiology, 1992